David A. Siegel Talis Biomedical Corp Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.81 - $1.44 $19,278 - $34,272
-23,800 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.3 - $4.19 $1,430 - $4,609
-1,100 Reduced 4.42%
23,800 $34,000
Q4 2021

Feb 14, 2022
BUY
$3.81 - $6.17 $94,869 - $153,633
24,900 New
24,900 $100,000

About Talis Biomedical Corp

TLIS Quotes by TradingView
  • Ticker TLIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 26,619,200
  • Market Cap $49.2M
  • Description
  • Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...
More about TLIS
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email